Latest filing published 03 Mar 2026 for Abbott Laboratories, €845k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Lisa D. Earnhardt across 2 companies, led by Abbott Laboratories and Intersect ENT, Inc. In total, 17 filings cover trades dated from 15 January 2016 to 27 February 2026.
Sales make up the whole of the open-market record (2 sales, €2.3M). The totals exclude 1 filing filed without an amount. Besides market trades, the filings include 13 share grants and 2 option exercises.
The latest filing, published on 3 March 2026, reports a share grant of €845k in Abbott Laboratories. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations